Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
The European Medicines Agency has accepted Teva’s Marketing Authorisation Application for olanzapine long-acting i...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...
MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...
Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
4D Path, a US-based company dedicated to personalising cancer care through a novel, physics-informed approach to predict...
Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO), announced a strategic pa...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI) and automat...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven biotechnology...
SK pharmteco, a leading global contract development and manufacturing organization (CDMO), and Prozomix, a pioneer ...
Hong Kong headquartered Insilico Medicine, a clinical-stage drug discovery and development company driven by genera...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development ...
In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...
Israel-based Evogene has announced a collaboration with the pioneering research group of Dr Mark Adams, a leading c...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
